Avidity Biosciences (RNAM) Stock Statistics & Valuation Metrics

Avidity Biosciences has a market cap or net worth of $11.30B. The enterprise value is $1.99B.

Avidity Biosciences has 155,149,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avidity Biosciences’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Avidity Biosciences is ―. Avidity Biosciences’s PEG ratio is -0.20.

In the last 12 months, Avidity Biosciences had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Avidity Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Avidity Biosciences upcoming earnings date is ―, ―.

Avidity Biosciences as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Avidity Biosciences has paid ― in taxes.

Avidity Biosciences EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Avidity Biosciences has ― in cash and marketable securities with $94.56M in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Avidity Biosciences is $72.75, which is 11.43% higher than the current price. The consensus rating is Hold